vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and MOVADO GROUP INC (MOV). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $186.1M, roughly 1.5× MOVADO GROUP INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 5.1%, a 91.2% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs 1.9%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 2.9%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Movado is a luxury American watch brand originally founded in 1881 in Switzerland. Movado means "movement" in Esperanto. The watches are known for their signature metallic dot at 12 o'clock and minimalist style; the company is best known for its Museum Watch.
ACAD vs MOV — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $186.1M |
| Net Profit | $273.6M | $9.6M |
| Gross Margin | 90.8% | 54.3% |
| Operating Margin | 6.1% | 6.3% |
| Net Margin | 96.3% | 5.1% |
| Revenue YoY | 9.4% | 1.9% |
| Net Profit YoY | 90.3% | 89.8% |
| EPS (diluted) | $1.61 | $0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $186.1M | ||
| Q3 25 | $278.6M | $161.8M | ||
| Q2 25 | $264.6M | $131.8M | ||
| Q1 25 | $244.3M | $181.5M | ||
| Q4 24 | $259.6M | $180.5M | ||
| Q3 24 | $250.4M | $157.0M | ||
| Q2 24 | $242.0M | $134.4M | ||
| Q1 24 | $205.8M | $175.8M |
| Q4 25 | $273.6M | $9.6M | ||
| Q3 25 | $71.8M | $3.0M | ||
| Q2 25 | $26.7M | $1.4M | ||
| Q1 25 | $19.0M | $8.1M | ||
| Q4 24 | $143.7M | $4.8M | ||
| Q3 24 | $32.8M | $3.5M | ||
| Q2 24 | $33.4M | $2.0M | ||
| Q1 24 | $16.6M | $9.8M |
| Q4 25 | 90.8% | 54.3% | ||
| Q3 25 | 92.2% | 54.1% | ||
| Q2 25 | 92.2% | 54.1% | ||
| Q1 25 | 91.7% | 54.2% | ||
| Q4 24 | 91.6% | 53.5% | ||
| Q3 24 | 92.5% | 54.3% | ||
| Q2 24 | 92.5% | 54.3% | ||
| Q1 24 | 88.8% | 53.5% |
| Q4 25 | 6.1% | 6.3% | ||
| Q3 25 | 12.8% | 2.5% | ||
| Q2 25 | 12.2% | 0.2% | ||
| Q1 25 | 7.9% | 5.1% | ||
| Q4 24 | 59.1% | 3.3% | ||
| Q3 24 | 12.6% | 1.7% | ||
| Q2 24 | 12.6% | 1.6% | ||
| Q1 24 | 7.4% | 6.1% |
| Q4 25 | 96.3% | 5.1% | ||
| Q3 25 | 25.8% | 1.8% | ||
| Q2 25 | 10.1% | 1.1% | ||
| Q1 25 | 7.8% | 4.4% | ||
| Q4 24 | 55.4% | 2.7% | ||
| Q3 24 | 13.1% | 2.2% | ||
| Q2 24 | 13.8% | 1.5% | ||
| Q1 24 | 8.0% | 5.6% |
| Q4 25 | $1.61 | $0.42 | ||
| Q3 25 | $0.42 | $0.13 | ||
| Q2 25 | $0.16 | $0.06 | ||
| Q1 25 | $0.11 | $0.36 | ||
| Q4 24 | $0.86 | $0.21 | ||
| Q3 24 | $0.20 | $0.15 | ||
| Q2 24 | $0.20 | $0.09 | ||
| Q1 24 | $0.10 | $0.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $183.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $497.5M |
| Total Assets | $1.6B | $751.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $183.9M | ||
| Q3 25 | $258.0M | $180.5M | ||
| Q2 25 | $253.6M | $203.1M | ||
| Q1 25 | $217.7M | $208.5M | ||
| Q4 24 | $319.6M | $181.5M | ||
| Q3 24 | $155.1M | $198.3M | ||
| Q2 24 | $177.1M | $225.4M | ||
| Q1 24 | $204.7M | $262.1M |
| Q4 25 | $1.2B | $497.5M | ||
| Q3 25 | $917.3M | $489.9M | ||
| Q2 25 | $822.4M | $493.2M | ||
| Q1 25 | $765.2M | $481.3M | ||
| Q4 24 | $732.8M | $491.3M | ||
| Q3 24 | $577.2M | $492.0M | ||
| Q2 24 | $516.7M | $489.6M | ||
| Q1 24 | $464.0M | $505.9M |
| Q4 25 | $1.6B | $751.9M | ||
| Q3 25 | $1.3B | $748.7M | ||
| Q2 25 | $1.2B | $747.2M | ||
| Q1 25 | $1.1B | $729.2M | ||
| Q4 24 | $1.2B | $747.2M | ||
| Q3 24 | $976.9M | $742.5M | ||
| Q2 24 | $914.1M | $736.0M | ||
| Q1 24 | $855.1M | $756.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $12.3M |
| Free Cash FlowOCF − Capex | — | $11.6M |
| FCF MarginFCF / Revenue | — | 6.2% |
| Capex IntensityCapex / Revenue | — | 0.4% |
| Cash ConversionOCF / Net Profit | -0.18× | 1.28× |
| TTM Free Cash FlowTrailing 4 quarters | — | $35.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $12.3M | ||
| Q3 25 | $74.3M | $-3.8M | ||
| Q2 25 | $64.0M | $-7.2M | ||
| Q1 25 | $20.3M | $39.1M | ||
| Q4 24 | $40.4M | $-4.7M | ||
| Q3 24 | $63.2M | $-17.8M | ||
| Q2 24 | $25.0M | $-18.1M | ||
| Q1 24 | $29.1M | $69.4M |
| Q4 25 | — | $11.6M | ||
| Q3 25 | $73.9M | $-5.1M | ||
| Q2 25 | — | $-8.7M | ||
| Q1 25 | — | $37.5M | ||
| Q4 24 | — | $-7.2M | ||
| Q3 24 | $63.2M | $-20.1M | ||
| Q2 24 | — | $-19.7M | ||
| Q1 24 | — | $67.8M |
| Q4 25 | — | 6.2% | ||
| Q3 25 | 26.5% | -3.1% | ||
| Q2 25 | — | -6.6% | ||
| Q1 25 | — | 20.7% | ||
| Q4 24 | — | -4.0% | ||
| Q3 24 | 25.2% | -12.8% | ||
| Q2 24 | — | -14.7% | ||
| Q1 24 | — | 38.6% |
| Q4 25 | — | 0.4% | ||
| Q3 25 | 0.1% | 0.8% | ||
| Q2 25 | — | 1.2% | ||
| Q1 25 | — | 0.9% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | 0.0% | 1.5% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | 0.9% |
| Q4 25 | -0.18× | 1.28× | ||
| Q3 25 | 1.03× | -1.27× | ||
| Q2 25 | 2.40× | -5.08× | ||
| Q1 25 | 1.07× | 4.86× | ||
| Q4 24 | 0.28× | -0.98× | ||
| Q3 24 | 1.93× | -5.14× | ||
| Q2 24 | 0.75× | -8.97× | ||
| Q1 24 | 1.76× | 7.06× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
MOV
| Other | $81.4M | 44% |
| Owned Brands Category | $46.0M | 25% |
| Sales Channel Directly To Consumer | $35.3M | 19% |
| Company Stores | $23.4M | 13% |
